Follow-The-Filings

Security · featured owners

TECH Bio-Techne Corp.

Health Care COM Equity as of 2026 Q2 among managers we track

  • 8 Owners
  • #167
  • Max 3.7%
  • Master 0.04%
  • $652M
  • 1 new 7 reduce

TECH (Bio-Techne Corp.) is held in 8 featured 13F books as of 2026 Q2. Ruane, Cunniff & Goldfarb is the largest tracked holder by portfolio weight (3.7%). Figures are as-filed 13F, not free float.

Who owns this now

Largest portfolio weights among featured holders · max 3.7% (Ruane, Cunniff & Goldfarb) · not free-float ownership

  1. Ruane, Cunniff & Goldfarb reduce 3.7%
  2. Wallace Weitz reduce 2.7%
  3. Mairs & Power reduce 1.8%
  4. Lee Ainslie reduce 0.96%
  5. George Soros new 0.46%
  6. Henry Ellenbogen reduce 0.34%

holders

sorted by value · long equity only · current book 2026 Q2 · open a manager for their book

history
Ruane, Cunniff & Goldfarb 2026 Q2 3.7% Reduce −1.3% 3,348,841 $237M history
Mairs & Power 2026 Q2 1.8% Reduce −1.8% 2,700,698 $191M history
Lee Ainslie - Maverick Capital 2026 Q2 0.96% Reduce −67.6% 1,535,610 $108M history
Wallace Weitz - Weitz Investment Management 2026 Q2 2.7% Reduce −16.8% 543,200 $38M history
George Soros - Soros Fund Management 2026 Q2 0.46% New 0.46% 535,400 $38M history
Henry Ellenbogen - Durable Capital Partners 2026 Q2 0.34% Reduce −88.7% 501,963 $35M history
Glenview Capital Management 2026 Q2 0.08% Reduce −68.7% 58,324 $4M history
Ron Baron - Bamco Inc. (Baron Capital) 2026 Q2 <0.01% Reduce −99.7% 1,800 $127K history

8 current · options excluded

SEC filings

Recent issuer filings from EDGAR · 13 shown · open Filing / Doc on SEC.gov

Filed Form Detail Links
8-K 8.01 Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
DEFA14A Filing Doc
10-K Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
DEFA14A SOLICITING MATERIAL Filing Doc
8-K 1.01,5.02,9.01 Filing Doc
8-K 7.01,9.01 Filing Doc
DEFA14A SOLICITING MATERIAL Filing Doc
8-K 2.02,8.01,9.01 Filing Doc
10-Q Filing Doc

Insider forms

Form 3 / 4 / 5 from EDGAR · 12 rows shown

Filed Form Detail Links
4 Period Aug 17, 2026 · 6 forms Filing Doc
4 Period Aug 15, 2026 · 6 forms Filing Doc
4 Period Jul 29, 2026 Filing Doc
4 Period Jul 28, 2026 Filing Doc
4 Period Jul 23, 2026 Filing Doc
4 Period Jun 2, 2026 Filing Doc
4 Period May 8, 2026 Filing Doc
4 Period May 5, 2026 · 3 forms Filing Doc
4 Period May 1, 2026 Filing Doc
4 Period Apr 22, 2026 · 2 forms Filing Doc
4 Period Apr 14, 2026 Filing Doc
4 Period Apr 3, 2026 Filing Doc

Updated about 18 hours ago Source: SEC EDGAR submissions All on EDGAR

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025 FY2026
Revenue $1.14B $1.16B $1.22B $1.22B
Gross profit $769.82M $769.72M $790.27M $799.07M
Gross margin * 67.7% 66.4% 64.8% 65.8%
Net income $285.26M $168.1M $73.4M —
Net margin * 25.1% 14.5% 6.0% —

Balance sheet

Metric FY2023 FY2024 FY2025 FY2026
Total current assets $621.48M $617.42M $608.3M $744.4M
Total non-current assets * $2.02B $2.09B $1.95B $1.84B
Total assets $2.64B $2.7B $2.56B $2.59B
Total current liabilities $128.51M $159.38M $175.85M $163.7M
Total equity $1.97B $2.07B — $2.11B

Cash flow

Metric FY2023 FY2024 FY2025 FY2026
Cash from operations $254.39M $298.98M $287.56M $292.07M
Cash from investing -$265.65M -$203.03M -$35.18M -$18.19M
Cash from financing $22.62M -$122.4M -$253.9M -$169.11M
Net change in cash $8M -$28.78M $10.4M $102.53M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders